• Author: Katherine I. Zhou
Clear all

Brief report: Real-world efficacy and safety of sotorasib in U.S. Veterans with KRAS G12C-mutated NSCLC

Abstract: Introduction: The KRAS G12C inhibitor sotorasib was approved for treating advanced NSCLC in the second line or later on the basis of the CodeBreaK100 trial. Nevertheless, …